ebook
Getting TiME on Your Side: Defining the future of precision medicine with advanced multiplexed immunofluorescence
Register here for download
You are currently viewing a placeholder content from HubSpot. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationRelevant for
FixVUE, InSituPlex, U-VUE
Description Overview highlighting the use of the InSituPlex® (ISP) a novel, robust mIF assay technology reliant on conjugating DNA barcodes to antibodies and using sequence-specific DNA-DNA hybridization tolabel antibodies for spatial profiling of immuno-oncology targets in FFPE tumor tissue
Want to meet with us? Check out our upcoming events.
Related Content
Learn more
poster
Improved Understanding of the Biology and Pathophysiology of the TME in PDAC Samples Revealed by Both InSituPlex and Imaging Mass Cytometry
Presented at AACR 2022
Learn more
poster
Comparative multiplex digital phenotyping of the tumor microenvironment across multiple tumor types using a well characterized multi-tumor tissue microarray
Presented at AACR 2021
Learn more
poster
Analysis of macrophages to the overall PD-L1 microenvironment using TMAs and InSituPlex
Presented at ASCO 2022
Learn more
poster
A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma
Learn more
poster
A workflow for cloud-based AI development of multiplex IF image analysis using the OMEROPlus platform
Presented at AACR 2024
